Facilitators of and barriers to buprenorphine initiation in the emergency department: a scoping review Bozinoff, Nikki et al. The Lancet Regional Health – Americas, Volume 38, 100899  https://www.thelancet.com/journals/lanam/article/PIIS26...

Prevalence of stimulant use and the role of opioid agonist treatment among people who inject drugs in France: Results from the COSINUS cohort study.  Roux P, Faye A, Sagaon-Teyssier L, Donadille C, Briand Madrid L, Carrieri MP, Maradan G, Ja...

Accessibility of methadone treatment via public transit for syringe services program participants in Miami-Dade County, Florida.  Plesons M, Malecki E, Ciraldo K, Ashbes E, Suarez E, Tookes HE, Bartholomew TS.  Res Sq [Preprint]. 2024 ...

Barriers and facilitators to implementing treatment for opioid use disorder in community hospitals.  Shearer R, Hagedorn H, Englander H, Siegler T, Kibben R, Fawole A, Patten A, Fitzpatrick A, Laes J, Fernando J, Appleton N, Oot E, Titus H, ...

Experiences Accessing Health and Social Services during and after Natural Disasters among People Who Use Drugs in Houston, Texas.  Paquette CE, Danns T, Bordeaux M, Cullins Z, Brinkley-Rubinstein L.  Int J Environ Res Public Health. 20...

Variation in Opioid Agonist Dosing in Clinical Trials by Race and Ethnicity.  Ross RK, Inose S, Shulman M, et al.  JAMA Netw Open. 2024;7(10):e2436612. doi:10.1001/jamanetworkopen.2024.36612 https://jamanetwork.com/journals/jaman...